On Invalid Date, Annovis Bio (NYSE: ANVS) reported Q3 2023 earnings per share (EPS) of -$1.63, up 106.33% year over year. Total Annovis Bio earnings for the quarter were -$14.72 million. In the same quarter last year, Annovis Bio's earnings per share (EPS) was -$0.79.
As of Q1 2024, Annovis Bio's earnings has grown year over year. Annovis Bio's earnings in the past year totalled -$37.09 million.
What is ANVS's earnings date?
Annovis Bio's earnings date is Invalid Date. Add ANVS to your watchlist to be reminded of ANVS's next earnings announcement.
What was ANVS's revenue last quarter?
On Invalid Date, Annovis Bio (NYSE: ANVS) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Annovis Bio's revenue was $0.00.
What was ANVS's revenue growth in the past year?
As of Q1 2024, Annovis Bio's revenue has grown null year over year. Annovis Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.